European Union supports Bavarian Nordic to cure Ebola

By Joachim Eeckhout

Bavarian Nordic has been granted €50M loan from the European Investment Bank (EIB) to support the companies’ pipeline including novel vaccines against Ebola and other infectious diseases as well as cancer immunotherapies. The loan is a three-to-five year bullet loan with fixed or variable interest payment. Bavarian Nordic has up Lire la suite

Source:: Labiotech

Les commentaires sont clos.